Prasad Chodavarapu
@omics-chap.bsky.social
Co-Founder @aganithaai.bsky.social | Transforming BioPharma R&D with Computational Biology/Chemistry and AI | Building multi-disciplinary teams | Author
Looking forward to the session at AIPM today. I'm planning to show in action, Aganitha Igniva™ agents for: hypothesis validation, target elucidation, protocol generation, MD results analysis, listening to voices of patients, HCPs and KOLs, and much more.
🚀Real-World Applications of #AgenticAI Accelerating #Biopharma R&D and Care
👉 Join us at AIPM-India 2025 in IIT Madras to see in action, Igniva™ AI agents, built on 5+ years of global biopharma R&D collaborations by 100+ researchers at Aganitha.
👉 Join us at AIPM-India 2025 in IIT Madras to see in action, Igniva™ AI agents, built on 5+ years of global biopharma R&D collaborations by 100+ researchers at Aganitha.
September 10, 2025 at 8:33 PM
Looking forward to the session at AIPM today. I'm planning to show in action, Aganitha Igniva™ agents for: hypothesis validation, target elucidation, protocol generation, MD results analysis, listening to voices of patients, HCPs and KOLs, and much more.
I’ve seen firsthand how many painful iterations multi-disciplinary teams go through to decode the biology hidden in #SingleCell #Omics data.
There has to be a faster way — one built for better collaboration, powered by #AI and #LLMs.
#DISTILL is our shot at doing this right.
There has to be a faster way — one built for better collaboration, powered by #AI and #LLMs.
#DISTILL is our shot at doing this right.
🔬 DISTILLing Complex Biology in the #SingleCell & #AgenticAI Era
Why should single cell #omics analysis still take months, even in 2025?
In this video, Ananya Jana explains the challenges single cell researchers face today and how DISTLL™ accelerates journey to insights.
youtu.be/dxszTx5YjKQ
Why should single cell #omics analysis still take months, even in 2025?
In this video, Ananya Jana explains the challenges single cell researchers face today and how DISTLL™ accelerates journey to insights.
youtu.be/dxszTx5YjKQ
Aganitha DISTILL™: DISTILLing complex biology in the Single cell & Agentic AI era
YouTube video by Aganitha AI
youtu.be
June 23, 2025 at 9:28 PM
I’ve seen firsthand how many painful iterations multi-disciplinary teams go through to decode the biology hidden in #SingleCell #Omics data.
There has to be a faster way — one built for better collaboration, powered by #AI and #LLMs.
#DISTILL is our shot at doing this right.
There has to be a faster way — one built for better collaboration, powered by #AI and #LLMs.
#DISTILL is our shot at doing this right.
If we’re to distribute the fruits of modern #science to all of humanity, we must find ways to scale access to expertise. #AI can be a powerful enabler on this path — augmenting human insight, accelerating development, and broadening accessibility.
📢 Personalized #GeneTherapy is here. #AI can help widen access.
A few days after KJ Muldoon was born, he was diagnosed with a rare genetic disorder. Doctors told his family:
“Your son is very sick. The best place in the world to be when your child is sick is next door.”
A few days after KJ Muldoon was born, he was diagnosed with a rare genetic disorder. Doctors told his family:
“Your son is very sick. The best place in the world to be when your child is sick is next door.”
May 28, 2025 at 8:26 PM
That’s probably it! Era of manual programming of software may now be in the past.
May 23, 2025 at 11:28 PM
That’s probably it! Era of manual programming of software may now be in the past.
Reflecting on #virtualcell: Given that no cell is an island, what's the chance of inferring biology looking at just a single cell's transcriptome? As a recent preprint (arxiv.org/abs/2503.03485) said, "After all, we do not have healthy or diseased annotations for individual cells." #singlecell
TEDDY: A Family Of Foundation Models For Understanding Single Cell Biology
Understanding the biological mechanism of disease is critical for medicine, and in particular drug discovery. AI-powered analysis of genome-scale biological data hold great potential in this regard. T...
arxiv.org
April 18, 2025 at 11:54 AM
Reflecting on #virtualcell: Given that no cell is an island, what's the chance of inferring biology looking at just a single cell's transcriptome? As a recent preprint (arxiv.org/abs/2503.03485) said, "After all, we do not have healthy or diseased annotations for individual cells." #singlecell
February 5, 2025 at 2:55 PM
In the panel discussion at #BiologicsWorkshop2025 in Goa last week, discussing #AI for #Bioprocess. Consensus was that AI adoption for meeting operational needs is proving easier than adoption for process optimisation given the regulated nature of bioprocesses.
February 4, 2025 at 5:36 AM
In the panel discussion at #BiologicsWorkshop2025 in Goa last week, discussing #AI for #Bioprocess. Consensus was that AI adoption for meeting operational needs is proving easier than adoption for process optimisation given the regulated nature of bioprocesses.
Loved the interactions at #BiologicsWorkshop2025 in Goa last week. I shared three case studies illustrating convergence of #AI and #DeepScience in the modeling and optimization of synthesis processes for mAb, mRNA and Gene therapies.
February 4, 2025 at 5:35 AM
Loved the interactions at #BiologicsWorkshop2025 in Goa last week. I shared three case studies illustrating convergence of #AI and #DeepScience in the modeling and optimization of synthesis processes for mAb, mRNA and Gene therapies.
Reposted by Prasad Chodavarapu
📢 Join us at #PMWC25 to talk about AI in BioPharma R&D
Vikram Duvvoori, CEO of Aganitha.ai, will be presenting case studies showing how #GenerativeAl & in silico modeling are mining insights from deep science to accelerate #BioPharma R&D. Event details in the poster below. See you there.
Vikram Duvvoori, CEO of Aganitha.ai, will be presenting case studies showing how #GenerativeAl & in silico modeling are mining insights from deep science to accelerate #BioPharma R&D. Event details in the poster below. See you there.
January 22, 2025 at 12:36 PM
📢 Join us at #PMWC25 to talk about AI in BioPharma R&D
Vikram Duvvoori, CEO of Aganitha.ai, will be presenting case studies showing how #GenerativeAl & in silico modeling are mining insights from deep science to accelerate #BioPharma R&D. Event details in the poster below. See you there.
Vikram Duvvoori, CEO of Aganitha.ai, will be presenting case studies showing how #GenerativeAl & in silico modeling are mining insights from deep science to accelerate #BioPharma R&D. Event details in the poster below. See you there.
Delighted to release this preprint - it was overdue. While a lot of advances happened in the meanwhile in #GenAI and protein language models, Autograd powered numerical optimization provides a direct approach to build upon datasets generated in large directed evolution screens. 🧬 🧪🧶🖥️
At Aganitha, we apply deep tech 🖥️ to learn from & build on the data generated by deep science 🧬 🧪
Sharing our preprint describing how we used #GenAI to improve design of blood-brain-barrier (#BBB) penetrating #AAV viral vectors 🧶 for gene therapy in brain disorders
www.biorxiv.org/content/10.1...
Sharing our preprint describing how we used #GenAI to improve design of blood-brain-barrier (#BBB) penetrating #AAV viral vectors 🧶 for gene therapy in brain disorders
www.biorxiv.org/content/10.1...
Learning from and improving upon high-throughput screens for protein fitness with Generative AI - Application to BBB-crossing AAV design
Deep Science is enabling high-throughput experimentation (HTE) to design novel biological entities with desired properties. E.g., blood-brain-barrier (BBB) crossing adeno- associated virus (AAV) vecto...
www.biorxiv.org
December 12, 2024 at 5:34 AM
Delighted to release this preprint - it was overdue. While a lot of advances happened in the meanwhile in #GenAI and protein language models, Autograd powered numerical optimization provides a direct approach to build upon datasets generated in large directed evolution screens. 🧬 🧪🧶🖥️